Hematologic: Platelets ? x ()/L; ANC ?. x ()/L (without platelet transfusion or growth factors within the days prior to the screening laboratory assessment)
Hemoglobin < g/dL at the screening visit; (NOTE: subject may not have received any growth factors or blood transfusions within seven days of the hematologic laboratory values obtained at the screening visit)
NOTE: patients may not have received any growth factors or blood transfusions within seven days of the hematologic laboratory values obtained at the screening visit
Hematologic: Platelets ? x ^/L; Hemoglobin ? . g/dL; absolute neutrophil count (ANC) ? . x ^/L (without platelet transfusion or any growth factors within previous days of the hematologic laboratory values obtained at screening visit)
Hematologic: Platelets ? x /L; Hemoglobin ? . g/dL; absolute neutrophil count (ANC) ? . x ^/L (without platelet transfusion or any granulocytic growth factors within previous days of the hematologic laboratory values obtained at screening visit)
Platelet count < ,/uL at the screening visit (note: patients may not have received any growth factors within days or blood transfusions within days of the hematologic laboratory values obtained at the screening visit)
Hemoglobin < . mmol/L ( g/dL) at the screening visit (note: patients may not have received any growth factors within days or blood transfusions within days of the hematologic laboratory values obtained at the screening visit)
Hematologic: Platelets ? x ^/L; Hemoglobin ? . g/ dL; Absolute neutrophil count (ANC) ? . x ^/L (without platelet transfusion or any growth factors within previous days of the hematologic laboratory values obtained at screening visit). Patients in the Group lymphoma expansion may be enrolled with an ANC of ? . x ^ /L; Platelets ? x ^ /L.
Absolute neutrophil count < ,/?L, platelet count < ,/?L, and hemoglobin < g/dL (NOTE: subject may not have received any growth factors or blood transfusions within seven days of the hematologic laboratory values obtained at the Screening visit)
